ProKidney Corp. (BMV:PROK)

ProKidney Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	84.94	99.12	60.65	490.25	20.56
Short-Term Investments	209.79	259.17	302.3	-	-
Cash & Short-Term Investments	294.73	358.29	362.95	490.25	20.56
Cash Growth	-31.70%	-1.28%	-25.97%	2284.73%	-
Other Receivables	1.78	2.45	1.38	-	-
Total Trade Receivables	1.78	2.45	1.38	-	-
Other Current Assets	27.94	35.15	9.82	14.47	6.71
Total Current Assets	324.44	395.88	374.15	504.72	27.27
Net Property, Plant & Equipment	47.69	45.19	46.41	13.06	12.6
Other Intangible Assets	-	-	-	0.21	0.43
Total Assets	372.13	441.07	420.55	518	40.3
Accounts Payable	2.44	3.63	5.1	3.04	2.83
Accrued Expenses	24.92	31.14	17.67	7.34	9.21
Current Portion of Leases	0.9	0.77	0.8	0.49	0.27
Other Current Liabilities	-	0.68	1.47	-	-
Total Current Liabilities	28.26	36.22	25.04	10.87	12.31
Long-Term Leases	3.52	2.47	3.61	1.91	1.07
Other Long-Term Liabilities	0.9	0.75	0.57	0.28	-
Total Long-Term Liabilities	4.42	3.22	4.18	2.18	1.07
Total Liabilities	32.68	39.44	29.22	13.06	13.38
Common Stock	0.03	0.03	0.02	0.02	188.43
Additional Paid-in Capital	231.58	205.74	36.11	7.48	-
Accumulated Other Comprehensive Income	0.03	0.13	0.13	-	-
Retained Earnings	-1,234	-1,201	-1,140	-1,104	-161.51
Minority Interest	1,342	1,397	1,495	1,602	-
Shareholders' Equity	-1,003	-994.95	-1,103	-1,097	26.92
Total Liabilities & Equity	372.13	441.07	420.55	518	40.3
Total Debt	4.42	3.24	4.41	2.4	1.33
Net Cash (Debt)	290.31	355.06	358.54	487.85	19.22
Net Cash Growth	-18.23%	-0.97%	-26.51%	2437.73%	-
Net Cash Per Share	2.26	3.63	5.81	7.93	-
Book Value	-1,003	-994.95	-1,103	-1,097	26.92
Book Value Per Share	-7.79	-10.16	-17.88	-17.82	-
Tangible Book Value	-1,003	-994.95	-1,103	-1,097	26.49
Tangible Book Value Per Share	-7.79	-10.16	-17.88	-17.82	-

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.